Sign in
4

Changes in Ownership

Nautilus Biotechnology, Inc. Filed Acc 0001062993-21-007983

Director bought 36,970 shares at an average $7.71 ($285,041)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
McIlwain Matthew S Director 2021-08-24 Purchase +13,568 $7.68 $104,269 335,673 D: show line 1 in the form
McIlwain Matthew S Director 2021-08-25 Purchase +11,693 $7.74 $90,458 347,366 D: show line 2 in the form
McIlwain Matthew S Director 2021-08-26 Purchase +11,709 $7.71 $90,314 359,075 D: show line 3 in the form
Open-market purchases · 36,970 sh · avg $7.71 · $285,041
Loading xslF345X03/form4.xml…